Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Migraine: Expanding our Tx arsenal.

McGrath K, Rague A, Thesing C, Collins E, Seecof O, Liantonio J.

J Fam Pract. 2019 Jan/Feb;68(1):10;14;16;24.

PMID:
30724899
2.

Pharmacological synergy: the next frontier on therapeutic advancement for migraine.

Blumenfeld A, Gennings C, Cady R.

Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6. Review.

PMID:
22221151
3.

Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosing.

Poston S, Dickson M, Johnsrud M, Rupnow MF, Gdovin JM, Bramley TJ, Armstrong RB.

Clin Ther. 2007 Mar;29(3):504-18.

PMID:
17577471
4.

Management of the acute migraine headache.

Aukerman G, Knutson D, Miser WF; Department of Family Medicine, Ohio State University College of Medicine and Public Health, Columbus, Ohio.

Am Fam Physician. 2002 Dec 1;66(11):2123-30. Review.

5.

Headache: migraine, magnetic stimulation and cortical excitability.

Lo YL.

Nat Rev Neurol. 2010 Aug;6(8):425-7. doi: 10.1038/nrneurol.2010.109.

PMID:
20689566
6.

Acute management of migraine.

Chowdhury D.

J Assoc Physicians India. 2010 Apr;58 Suppl:21-5.

PMID:
21049703
7.

Novel therapeutic targets.

Geppetti P, Trevisani M, Nicoletti P, Capone JG.

Neurol Sci. 2006 May;27 Suppl 2:S111-4. Review.

PMID:
16688612
8.

[New triptan preparations can help the migraine patient. Pharmacodynamic and pharmacokinetic progresses].

Dahlöf CG.

Lakartidningen. 1998 Nov 11;95(46):5175, 5178-82, 5184-6. Review. Swedish.

PMID:
9842191
9.

Multiple sclerosis: new treatment trials and emerging therapeutic targets.

DeAngelis T, Lublin F.

Curr Opin Neurol. 2008 Jun;21(3):261-71. doi: 10.1097/WCO.0b013e328300c70d. Review.

PMID:
18451708
10.

Behavioral treatment of migraine in children and adolescents.

Baumann RJ.

Paediatr Drugs. 2002;4(9):555-61. Review.

PMID:
12175270
11.

Migraine overview and summary of current and emerging treatment options.

Peters GL.

Am J Manag Care. 2019 Jan;25(2 Suppl):S23-S34.

12.

Travelling along a road with obstacles: experiences of managing life to feel well while living with migraine.

Rutberg S, Ohrling K, Kostenius C.

Int J Qual Stud Health Well-being. 2013 Feb 5;8:1-9. doi: 10.3402/qhw.v8i0.19900.

13.

A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.

Reuter U.

Headache. 2018 May;58 Suppl 1:48-59. doi: 10.1111/head.13302.

PMID:
29697156
14.

The therapeutic potential of novel anti-migraine acute therapies.

Sabato D, Lionetto L, Martelletti P.

Expert Opin Investig Drugs. 2015 Feb;24(2):141-4. doi: 10.1517/13543784.2015.983223. Epub 2014 Nov 13.

PMID:
25391253
15.

Menstrual migraine.

Recober A, Geweke LO.

Curr Neurol Neurosci Rep. 2005 Mar;5(2):93-8. Review.

PMID:
15743545
16.

CGRP mechanism antagonists and migraine management.

Karsan N, Goadsby PJ.

Curr Neurol Neurosci Rep. 2015 May;15(5):25. doi: 10.1007/s11910-015-0547-z. Review.

PMID:
25790955
17.

CGRP receptor antagonists: a new choice for acute treatment of migraine?

Durham PL.

Curr Opin Investig Drugs. 2004 Jul;5(7):731-5. Review.

PMID:
15298069
18.

The medical management of migraine.

Bigal ME, Lipton RB, Krymchantowski AV.

Am J Ther. 2004 Mar-Apr;11(2):130-40. Review.

PMID:
14999365
19.

Comparative tolerability of treatments for acute migraine: A network meta-analysis.

Thorlund K, Toor K, Wu P, Chan K, Druyts E, Ramos E, Bhambri R, Donnet A, Stark R, Goadsby PJ.

Cephalalgia. 2017 Sep;37(10):965-978. doi: 10.1177/0333102416660552. Epub 2016 Aug 12. Review.

PMID:
27521843
20.

Migraine and stroke: current perspectives.

Elliott D.

Neurol Res. 2008 Oct;30(8):801-12. doi: 10.1179/174313208X341049. Review.

PMID:
18826806

Supplemental Content

Support Center